Leap Therapeutics (FRA:5MC) 3-Year Book Growth Rate : -33.00% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Leap Therapeutics 3-Year Book Growth Rate?

Leap Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €1.70.

During the past 12 months, Leap Therapeutics's average Book Value per Share Growth Rate was -22.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was -33.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 12 years, the highest 3-Year average Book Value per Share Growth Rate of Leap Therapeutics was 81.10% per year. The lowest was -33.00% per year. And the median was -4.60% per year.

Competitive Comparison of Leap Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Leap Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Leap Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Leap Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Leap Therapeutics's 3-Year Book Growth Rate falls into.

Leap Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Leap Therapeutics (FRA:5MC) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Leap Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Leap Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Leap Therapeutics (FRA:5MC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Leap Therapeutics Inc (FRA:5MC) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

LPTX:USA

Address

47 Thorndike Street, Suite B1-1, Cambridge, MA, USA, 02141

Website

https://www.leaptx.com

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P204,and P205.

Leap Therapeutics (FRA:5MC) Headlines

No Headlines